Society of Breast Imaging (SBI)

The core purpose of the Society of Breast Imaging (SBI) is to save lives and minimize the impact of breast cancer. SBI says it is a champion for the science of breast health, scientific integrity in women's health and fosters collaboration among breast imagers. SBI works closely with the American College of Radiology (ACR) on many policies and issues regarding mammography.

RSS icon
  • Debra L. Monticciolo, MD, FACR, FSBI, past-president of both the Society of Breast Imaging (SBI), and the American College of Radiology (ACR), explains the current recommendations and a study she did looking at real patient data and projected outcomes using different screening parameters.

    The debate over when women should start breast screenings

    Debra Monticciolo, MD, who has previously led both the Society of Breast Imaging and the American College of Radiology, discussed how different screening strategies may impact patient outcomes.

  • Telemammography

    4 key trends in breast imaging

    These trends include growth in 3D mammography, supplemental imaging for women with dense breasts and in the role of artificial intelligence.

  • Breast screening mammogram during the COVID pandemic. COVID significantly impacted breast imaging. Image courtesy of Novant Health

    VIDEO: Impact of COVID on breast imaging

    Connie Lehman, MD, PhD, chief of breast imaging, co-director of the Avon Comprehensive Breast Evaluation Center at the Massachusetts General Hospital, discusses the challenges of the COVID-19 pandemic on breast screenings, increased cancer rates and issues with the vaccines causing false positives on mammograms.

  • Society of Breast Imaging (SBI) President John Lewin, MD, explains some of new initiatives and technology in mammography to increase earlier breast cancer detection. #SBI #breastimaging #mammography

    VIDEO: SBI president outlines trends in breast imaging

    Society of Breast Imaging President John Lewin, MD, explains some of the new initiatives and technology in mammography that are designed to increase early breast cancer detection.

  • Interview with Stamatia Destounis, MD, FACR, a radiologist and managing partner at Elizabeth Wende Breast Care in Rochester, New York, chair of the American College of Radiology (ACR) Breast Commission, serves on the Public Information Advisors Committee for Radiological Society of North America (RSNA) and on the Society of Breast Imaging (SBI) Communication Committee. She discusses post-COVID economic issues facing breast imaging centers, including the "great resignation" and lower reimbursements.

    VIDEO: Issues with the great resignation and lower reimbursements in breast imaging

    Stamatia Destounis, MD, FACR, a radiologist and managing partner at Elizabeth Wende Breast Care in Rochester, New York, and chair of the ACR Breast Commission, discusses post-COVID-19 economic issues facing breast imaging centers, including staffing problems from the "Great Resignation" and lower reimbursements. 

Thumbnail

Danish study challenges value of screening mammography, draws sharp criticism from U.S. orgs

European researchers have reviewed a huge mammography dataset and found no association between screening mammography and a reduction in the incidence of advanced breast cancer. 

Comparison of a 2D digital mammogram and breast tomosynthesis 3D mammography from UCSF.

Breast density website reminds patients to dig deeper on internet searches

A website offering information about dense breasts, Dense Breast Info, wants women to be aware of their services, even though they aren’t always the first result in an internet search about breast density. 

Annual Mammography Starting at Age 40 Still Best Way to Saves Lives from Breast Cancer

The American College of Radiology (ACR), Society of Breast Imaging (SBI) and major medical organizations experienced in breast cancer care continue to recommend that women start getting annual mammograms at age 40.

Thumbnail

False-positives and fear

Research has once again shown that false-positive screening mammography results lead to increased anxiety for the women that receive them, and that these feelings can last for months. But how much should we fear the fear itself?

Thumbnail

Capitol briefing takes aim at USPSTF mammo guidelines

A congresswoman with a personal breast cancer story joined imaging experts for a Capitol Hill briefing that served both to illuminate the importance of mammography screening and also condemn recent U.S. Preventive Services Task Force mammography guidelines.

Volpara Solutions releases VolparaDensity 3.1 for use with tomosynthesis systems from multiple manufacturers at SBI

Volpara Solutions today announced the release of VolparaDensity version 3.1 here at the Society of Breast Imaging’s SBI/ACR Breast Imaging Symposium in Orlando, Fla., April 25-28, 2015 (SBI Booth #214).

Example of a mammogram showing X-ray images of both the right and left breast and patches of dense breast tissue.

ACR, SBI launch screening mammo offense

A study published March 18 in Annals of Family Medicine that detailed long-term psychosocial harms of false-positive screening mammograms is compromised by methodological irregularities, underplays the harm of a breast cancer diagnosis and does not address existing strategies used to minimize anxiety, according to statements by the American College of Radiology (ACR), the Society of Breast Imaging (SBI) and breast imaging experts.

Example of a mammogram showing X-ray images of both the right and left breast and patches of dense breast tissue.

ACR & SBI: Norwegian mammo overdiagnosis analysis flawed

The American College of Radiology (ACR) and the Society of Breast Imaging (SBI) have responded to a study in the Annals of Internal Medicine which concluded that 15 to 25 percent of cancers in the Norwegian mammography screening program are overdiagnosed, saying those overdiagnosis rates are overestimated, according to a statement on ACRs website.

Displaying 17 - 24 of 25

Around the web

Cardiovascular Business
A closer look at how FDA's flurpiridaz approval will impact nuclear cardiology

The newly approved PET radiotracer is expected to improve patient care significantly. “We have been able to reach the pinnacle of myocardial perfusion imaging with flurpiridaz," one expert said.

Cardiovascular Business
'This could be a paradigm shift': How PET with newly approved flurpiridaz compares to SPECT

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Cardiovascular Business
Ultrafast myocardial contrast echocardiography shows early potential to evaluate CAD

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Design by Adaptive Theme
Trimed Popup
Trimed Popup